Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

• Status: Completed
• Trial end date: 2004-09-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
• Collaborator: Otsuka America Pharmaceutical
• Treatments: Aripiprazole

Criteria

Inclusion Criteria:

• Men and women, ages 18 and older, with a worsening of schizophrenia symptoms over the past three months